Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Mulpleo (previously Lusutrombopag Shionogi), lusutrombopag, Date of authorisation: 18/02/2019, Revision: 9, Status: Authorised
TO: